Search Ontology:
ChEBI

molnupiravir

Term ID
CHEBI:180653
Synonyms
  • beta-D-N(4)-hydroxycytidine-5'-isopropyl ester
  • EIDD 1931 5'-isopropylester
  • EIDD 2801
  • EIDD-2801
  • MK-4482
  • molnupiravir
  • molnupiravirum
  • N(4)-hydroxycytidine 5'-isopropylester
  • N-hydroxy-5'-O-(2-methylpropanoyl)-3,4-dihydrocytidine
  • {(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl]tetrahydrofuran-2-yl}methyl 2-methylpropanoate
Definition
A nucleoside analogue that is N4-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N4-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19.
References
  • cas:2349386-89-4
  • cas:2492423-29-5
  • chemspider:84400552
  • kegg.drug:D11943
  • pmc:PMC8461366
  • pubmed:31645453
  • pubmed:31910262
  • pubmed:31945316
  • pubmed:32253226
  • pubmed:32503814
  • pubmed:32714193
  • pubmed:33030468
  • pubmed:33273742
  • pubmed:33290476
  • pubmed:33561864
  • pubmed:33588727
  • pubmed:33649113
  • pubmed:33664631
  • pubmed:33863887
  • pubmed:33902254
  • pubmed:33961695
  • pubmed:33989635
  • pubmed:34056192
  • pubmed:34118236
  • pubmed:34244768
  • pubmed:34271264
  • pubmed:34337170
  • pubmed:34381216
  • pubmed:34425873
  • pubmed:34509661
  • pubmed:34518697
  • pubmed:34571361
  • wikipedia.en:Molnupiravir
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from molnupiravir
Phenotype where environments contain molnupiravir
Phenotype modified by environments containing molnupiravir
Phenotype affecting molnupiravir
Human Disease Model